Peripheral B Cell Deficiency and Predisposition to Viral Infections: The Paradigm of Immune Deficiencies

Area of Science:

• Immunology
• Virology
• Genetics

Background:

• Understanding humoral immunity's role in viral infections is crucial, especially during the COVID-19 pandemic.
• Patients with B cell alymphocytosis provide a unique model to study immune responses to viruses.
• Key conditions include X-linked agammaglobulinemia (XLA), Good's syndrome, and Common Variable Immune Deficiency (CVID).

Purpose of the Study:

• To review existing evidence on viral infections in patients with B cell alymphocytosis.
• To highlight the predisposition to adverse outcomes in individuals with very low circulating B cells.
• To examine the link between B cell alymphocytosis and prognosis in SARS-CoV-2 infection.

Main Methods:

• Literature review of studies on viral infections in patients with B cell deficiencies.
• Analysis of data concerning XLA, Good's syndrome, CVID, and post-monoclonal antibody therapy.
• Synthesis of evidence regarding outcomes of viral infections, including SARS-CoV-2.

Main Results:

• Viral infections are more common than previously assumed in patients with B cell alymphocytosis.
• Individuals with very low B cell counts appear predisposed to negative health outcomes from viral infections.
• Peripheral B cell alymphocytosis correlates with a poor prognosis for SARS-CoV-2 infection.

Conclusions:

• Humoral immunity, mediated by B cells, plays a significant role in controlling viral infections.
• B cell deficiencies increase susceptibility and risk of severe outcomes during viral illnesses.
• Further research is needed to optimize management and treatment strategies for these patients.